+467.0%
MRNA vs DUOL
-51.5%
+518.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DUOL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.0% | +6.4% | +5.7% |
| 7D | -1.1% | -7.0% | +5.9% | +1.1% |
| 30D | +126.1% | +6.7% | +119.4% | +125.4% |
| 3M | +190.0% | +16.0% | +174.0% | +187.0% |
| 6M | +157.2% | +45.4% | +111.8% | +151.1% |
| YTD | +388.2% | -18.1% | +406.3% | +409.3% |
| 1Y | +467.0% | -53.6% | +520.6% | +501.8% |
| All | +467.0% | -51.5% | +518.5% | +501.8% |
Cumulative growth
Daily Returns
Daily percentage return beside DUOL.
Daily Out/Under-Performance
Portfolio return minus DUOL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DUOL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DUOL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling